{"id":51718,"date":"2022-12-08T13:06:40","date_gmt":"2022-12-08T12:06:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/"},"modified":"2022-12-08T13:06:40","modified_gmt":"2022-12-08T12:06:40","slug":"nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/","title":{"rendered":"NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit"},"content":{"rendered":"
\n

BOSTON–(BUSINESS WIRE)–NextRNA Therapeutics, a biotechnology company unlocking the potential of non-coding RNAs to develop novel and transformative therapeutics, today announced that Dominique Verhelle, Ph.D., Co-Founder, Chief Executive Officer and Chief Scientific Officer, will give a corporate presentation at the 5th<\/sup> Annual RNA-Targeted Drug Discovery Summit, which will be held December 13 \u2013 15, 2022 in Boston.\n<\/p>\n

<\/a><\/p>\n

\nDr. Verhelle\u2019s presentation, which is scheduled to take place on Thursday, December 15 at 1:15 p.m., will explore NextRNA\u2019s proprietary target and drug discovery engine to identify, validate and disrupt disease-relevant interactions between long non-coding RNAs and RNA-binding proteins with small molecules.\n<\/p>\n

\nAbout NextRNA Therapeutics\u00a0
\n
<\/b>NextRNA is a biotechnology company unlocking the potential of non-coding RNAs to develop transformative medicines for multiple diseases. The company is leveraging its proprietary technology platform to identify non-coding RNAs and their interacting proteins responsible for disease, and to develop selective small molecules to disrupt these interactions.\n<\/p>\n

\nFor more information, please visit www.nextrnatx.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
Liz Melone
\n
PR@NextRNA.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BOSTON–(BUSINESS WIRE)–NextRNA Therapeutics, a biotechnology company unlocking the potential of non-coding RNAs to develop novel and transformative therapeutics, today announced that Dominique Verhelle, Ph.D., Co-Founder, Chief Executive Officer and Chief Scientific Officer, will give a corporate presentation at the 5th Annual RNA-Targeted Drug Discovery Summit, which will be held December 13 \u2013 15, 2022 in … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51718","6":"format-standard","7":"category-industry"},"yoast_head":"\nNextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOSTON–(BUSINESS WIRE)–NextRNA Therapeutics, a biotechnology company unlocking the potential of non-coding RNAs to develop novel and transformative therapeutics, today announced that Dominique Verhelle, Ph.D., Co-Founder, Chief Executive Officer and Chief Scientific Officer, will give a corporate presentation at the 5th Annual RNA-Targeted Drug Discovery Summit, which will be held December 13 \u2013 15, 2022 in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-08T12:06:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221208005246\/en\/1658843\/21\/NextRNA-Logo-FullColor_300pxwide.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit\",\"datePublished\":\"2022-12-08T12:06:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\\\/\"},\"wordCount\":175,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221208005246\\\/en\\\/1658843\\\/21\\\/NextRNA-Logo-FullColor_300pxwide.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\\\/\",\"name\":\"NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221208005246\\\/en\\\/1658843\\\/21\\\/NextRNA-Logo-FullColor_300pxwide.jpg\",\"datePublished\":\"2022-12-08T12:06:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221208005246\\\/en\\\/1658843\\\/21\\\/NextRNA-Logo-FullColor_300pxwide.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221208005246\\\/en\\\/1658843\\\/21\\\/NextRNA-Logo-FullColor_300pxwide.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/","og_locale":"en_US","og_type":"article","og_title":"NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit - Pharma Trend","og_description":"BOSTON–(BUSINESS WIRE)–NextRNA Therapeutics, a biotechnology company unlocking the potential of non-coding RNAs to develop novel and transformative therapeutics, today announced that Dominique Verhelle, Ph.D., Co-Founder, Chief Executive Officer and Chief Scientific Officer, will give a corporate presentation at the 5th Annual RNA-Targeted Drug Discovery Summit, which will be held December 13 \u2013 15, 2022 in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-08T12:06:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221208005246\/en\/1658843\/21\/NextRNA-Logo-FullColor_300pxwide.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit","datePublished":"2022-12-08T12:06:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/"},"wordCount":175,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221208005246\/en\/1658843\/21\/NextRNA-Logo-FullColor_300pxwide.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/","url":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/","name":"NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221208005246\/en\/1658843\/21\/NextRNA-Logo-FullColor_300pxwide.jpg","datePublished":"2022-12-08T12:06:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221208005246\/en\/1658843\/21\/NextRNA-Logo-FullColor_300pxwide.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221208005246\/en\/1658843\/21\/NextRNA-Logo-FullColor_300pxwide.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/nextrna-therapeutics-to-participate-in-upcoming-5th-annual-rna-targeted-drug-discovery-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51718"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51718\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51718"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}